
Ashish P Thakrar, MD
Assistant Professor of Medicine (General Internal Medicine)
Department: Medicine
Contact information
423 Guardian Drive, Blockley Hall
Philadelphia, PA 19104
Philadelphia, PA 19104
Publications
Education:
BS (Economics)
Carnegie Mellon University, 2012.
BFA (Piano Performance)
Carnegie Mellon University, 2012.
MD
University of Pennsylvania School of Medicine, 2017.
MS (Health Policy Research)
University of Pennsylvania, 2023.
BS (Economics)
Carnegie Mellon University, 2012.
BFA (Piano Performance)
Carnegie Mellon University, 2012.
MD
University of Pennsylvania School of Medicine, 2017.
MS (Health Policy Research)
University of Pennsylvania, 2023.
Post-Graduate Training
Post-Baccalaureate Premedical Program, Johns Hopkins University, Baltimore, MD, 2012-2013.
Resident in Internal Medicine, Johns Hopkins Hospital Osler Medical Residency, 2017-2020.
Addiction Medicine Fellow, Johns Hopkins Bayview Medical Center, Baltimore, MD, 2020-2021.
National Clinical Scholar Program, University of Pennsylvania, 2021-Present.
MSc Health Policy Research, University of Pennsylvania, 2021-Present.
Post-Baccalaureate Premedical Program, Johns Hopkins University, Baltimore, MD, 2012-2013.
Resident in Internal Medicine, Johns Hopkins Hospital Osler Medical Residency, 2017-2020.
Addiction Medicine Fellow, Johns Hopkins Bayview Medical Center, Baltimore, MD, 2020-2021.
National Clinical Scholar Program, University of Pennsylvania, 2021-Present.
MSc Health Policy Research, University of Pennsylvania, 2021-Present.
Certifications
American Board of Internal Medicine Certified, 2020.
Addiction Medicine Certified from the American Board of Preventive Medicine, 2021.
Permanent linkAmerican Board of Internal Medicine Certified, 2020.
Addiction Medicine Certified from the American Board of Preventive Medicine, 2021.
Selected Publications
Lutz L, MD; McFadden R, RN, MPH; Xu L, MS; Ranvir Bhatia, MD; M. Holliday Davis, MA; Natasa Rohacs, BA; Jenny Wei, MD; Jeanmarie Perrone, MD; Margaret Lowenstein, MD, MPhil, MSHP; Thakrar AP, MD, MS: Wound Characteristics Among Patients Exposed to Xylazine. JAMA Dermatology Nov 2024.Barr GA, Schmidt HD, Thakrar AP, Kranzler HR, Liu R.: Revisiting dezocine for opioid use disorder: A narrative review of its potential abuse liability. CNS Neurosci Ther Oct 2024.
Thakrar AP, Christine PJ, Siaw-Asamoah A, Spadaro A, Faude S, Snider CK, Delgado MK, Lowenstein M, Kampman K, Perrone J, Nelson LS, Kilaru AS.: Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl. JAMA Network Open 7: e2435895, Sep 2024.
Englander H, Thakrar AP, Bagley SM, Rolley T, Dong K, Hyshka E.: Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review. JAMA Internal Medicine 184: 691-701, Jun 2024.
Kleinman RA, Thakrar AP.: Recours aux opioïdes à action rapide pour soulager les symptômes de sevrage des opioïdes en milieu hospitalier. CMAJ 196: E386-E389, Mar 2024.
Stern SJ, D'Orazio JL, Work BD, Calcaterra SL, Thakrar AP.: Point/counterpoint: Should full agonist opioid medications be offered to hospitalized patients for management of opioid withdrawal? J Hosp Med Feb 2024.
McFadden R, Wallace-Keeshen S, Petrillo Straub K, Hosey RA, Neuschatz R, McNulty K, Thakrar AP.: Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in Philadelphia. J Addict Med Jan 2024.
Kleinman RA, Thakrar AP.: Using short-acting opioids to relieve opioid withdrawal in hospital. CMAJ 195: E1718-E1720, Dec 2023.
Thakrar AP, Lowenstein M, Greysen SR, Delgado MK.: Trends in Before Medically Advised Discharges for Patients With Opioid Use Disorder, 2016-2020. JAMA 330: 2302-2304, Dec 2023.
Becker TD, Eschliman EL, Thakrar AP, Yang LH.: A conceptual framework for how structural changes in emerging acute substance use service models can reduce stigma of medications for opioid use disorder. Front Psychiatry 14: 1184951, Sep 2023.